You have 9 free searches left this month | for more free features.

lantus®

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 1 Diabetes Trial in Worldwide (Mylan's insulin glargine, Lantus®)

Completed
  • Type 1 Diabetes Mellitus
  • Mylan's insulin glargine
  • Lantus®
  • Fresno, California
  • +80 more
Mar 1, 2022

Type 1 Diabetes Trial in China (LY2963016, Lantus®, Insulin Lispro)

Completed
  • Type 1 Diabetes
  • Beijing, Beijing, China
  • +19 more
Mar 3, 2021

Type 2 Diabetes Trial in China (LY2963016, Lantus®)

Completed
  • Type 2 Diabetes
  • Hefei, Anhui, China
  • +31 more
May 3, 2021

Type 2 Diabetes Trial in Worldwide (Mylan's insulin glargine, Lantus®)

Completed
  • Type 2 Diabetes
  • Mylan's insulin glargine
  • Lantus®
  • Chandler, Arizona
  • +119 more
Mar 1, 2022

Type 1 Diabetes Trial in Worldwide (Mylan's insulin glargine, Lantus®)

Completed
  • Type 1 Diabetes
  • Mylan's insulin glargine
  • Lantus®
  • Bell Gardens, California
  • +161 more
Mar 1, 2022

Clamp Study Trial in Moscow, Saint Petersburg (RinGlar®, Lantus®)

Completed
  • Clamp Study
  • Moscow, Russian Federation
  • +1 more
Sep 23, 2019

Type 2 Diabetes Trial in Mainz, Neuss (BioChaperone® Combo, Humalog® Mix25, Humalog®)

Completed
  • Type 2 Diabetes Mellitus
  • BioChaperone® Combo
  • +4 more
  • Mainz, Germany
  • +1 more
Jun 28, 2017

Diabetes, Type 2 Trial in Worldwide (LY2963016, LANTUS®, Oral Antihyperglycemic Medication)

Completed
  • Diabetes Mellitus, Type 2
  • Miami, Florida
  • +43 more
Sep 25, 2017

Diabetes, Type 2 Trial (Lantus®)

Completed
  • Diabetes Mellitus, Type 2
  • Lantus®
  • (no location specified)
Jul 20, 2009